- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske studier sponset av Global Alliance for TB Drug Development
Totalt 43 resultater
-
Global Alliance for TB Drug DevelopmentFullførtTuberkulose | Tuberkulose, lunge | Tuberkulose, multiresistent | Tuberkulose, MDR | Medikamentresistent tuberkuloseTanzania, Georgia, Den russiske føderasjonen, Brasil, Malaysia, Filippinene, Sør-Afrika, Uganda
-
Global Alliance for TB Drug DevelopmentFullførtTuberkulose | Tuberkulose, lungeForente stater
-
Global Alliance for TB Drug DevelopmentFullførtTuberkulose | Tuberkulose, lungeForente stater
-
Global Alliance for TB Drug DevelopmentFullførtMultiresistent tuberkuloseForente stater
-
Global Alliance for TB Drug DevelopmentFullført
-
Global Alliance for TB Drug DevelopmentFullførtTuberkulose | Tuberkulose, lungeForente stater
-
Global Alliance for TB Drug DevelopmentFullførtLungetuberkuloseSør-Afrika
-
Global Alliance for TB Drug DevelopmentFullført
-
Global Alliance for TB Drug DevelopmentFullført
-
Global Alliance for TB Drug DevelopmentAvsluttet
-
Global Alliance for TB Drug DevelopmentFullført
-
Global Alliance for TB Drug DevelopmentFullført
-
Global Alliance for TB Drug DevelopmentFullførtTuberkulose, lunge, medikamentfølsom | Tuberkulose, lunge, multiresistentSør-Afrika, Zambia, Georgia, Filippinene, Kenya, Malaysia, Tanzania, Uganda
-
Global Alliance for TB Drug DevelopmentFullført
-
Global Alliance for TB Drug DevelopmentFullført
-
Global Alliance for TB Drug DevelopmentFullførtTuberkulose | Tuberkulose, lungeForente stater
-
Global Alliance for TB Drug DevelopmentFullførtLungetuberkuloseSør-Afrika
-
Global Alliance for TB Drug DevelopmentFullførtTuberkuloseForente stater
-
Global Alliance for TB Drug DevelopmentRekrutteringMedikamentsensitiv tuberkulose | Lungetuberkulose | Lunge-TBFilippinene, Sør-Afrika, Tanzania, Georgia, Uganda
-
Global Alliance for TB Drug DevelopmentAktiv, ikke rekrutterendeTuberkulose | Tuberkulose, lunge | Tuberkulose, multiresistent | Tuberkulose, MDR | Medikamentresistent tuberkuloseGeorgia, Sør-Afrika
-
Global Alliance for TB Drug DevelopmentFullførtTuberkulose | Tuberkulose, lunge | Tuberkulose, multiresistent | Utstrakt legemiddelresistent tuberkulose | Tuberkulose, MDR | XDR-TB | Pre-XDR-TBSør-Afrika, Den russiske føderasjonen, Georgia, Moldova, Republikken
-
Global Alliance for TB Drug DevelopmentFullførtTuberkulose | Tuberkulose, lunge | Lungesykdom | Multiresistent tuberkulose | Medikamentsensitiv tuberkulose | Medikamentresistent tuberkulose | Mycobacterium Tuberculosis-infeksjonForente stater
-
Global Alliance for TB Drug DevelopmentFullførtTuberkulose | Tuberkulose, lunge | Lungesykdom | Multiresistent tuberkulose | Medikamentsensitiv tuberkulose | Medikamentresistent tuberkulose | Mycobacterium Tuberculosis-infeksjonForente stater
-
Global Alliance for TB Drug DevelopmentFullført
-
Global Alliance for TB Drug DevelopmentFullførtTuberkuloseForente stater
-
Global Alliance for TB Drug DevelopmentFullført
-
Global Alliance for TB Drug DevelopmentFullførtLungetuberkuloseSør-Afrika
-
Global Alliance for TB Drug DevelopmentFullførtLungetuberkuloseSør-Afrika
-
Global Alliance for TB Drug DevelopmentQPS Holdings LLCFullført
-
Centers for Disease Control and PreventionBayer; Global Alliance for TB Drug DevelopmentFullførtTuberkuloseUganda, Forente stater, Sør-Afrika, Canada, Brasil, Spania
-
Universitas PadjadjaranRadboud University Medical Center; Global Alliance for TB Drug DevelopmentFullførtTuberkulose, meningeal | LinezolidIndonesia
-
Bill & Melinda Gates Medical Research InstituteGlobal Alliance for TB Drug Development; Janssen Pharmaceutica; Otsuka Pharmaceutical...RekrutteringLungetuberkuloseFilippinene, Sør-Afrika
-
Global Alliance for TB Drug DevelopmentSanofi; University College, London; European and Developing Countries Clinical... og andre samarbeidspartnereFullførtLungetuberkuloseKina, Zambia, Tanzania, India, Kenya, Malaysia, Mexico, Sør-Afrika, Thailand
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development... og andre samarbeidspartnereRekrutteringTuberkulose | Rifampicin-resistent tuberkuloseBrasil, India, Sør-Afrika, Tanzania, Thailand
-
Centre for the AIDS Programme of Research in South...Amsterdam Institute for Global Health and Development; Global Alliance... og andre samarbeidspartnereRekrutteringTuberkulose | Resistent tuberkulose | MDR-TB | XDR-TBNigeria, Sør-Afrika, Etiopia
-
The Aurum Institute NPCLudwig-Maximilians - University of Munich; Global Alliance for TB Drug... og andre samarbeidspartnereRekruttering
-
Institut de Recherche pour le DeveloppementGlobal Alliance for Improved Nutrition; National Institute of Nutrition... og andre samarbeidspartnereFullført
-
Medecins Sans Frontieres, NetherlandsLondon School of Hygiene and Tropical Medicine; University College, London og andre samarbeidspartnereAktiv, ikke rekrutterendeMultiresistent tuberkulose | Lungetuberkulose | Utstrakt legemiddelresistent tuberkuloseHviterussland, Sør-Afrika
-
Medecins Sans Frontieres, NetherlandsLondon School of Hygiene and Tropical Medicine; University College, London og andre samarbeidspartnereAktiv, ikke rekrutterendeTuberkulose, lunge | Tuberkulose, multiresistent | Utstrakt legemiddelresistent tuberkuloseHviterussland, Sør-Afrika, Usbekistan
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); Université de Montréal; International... og andre samarbeidspartnereFullførtHypertensjon | Diabetes mellitus, type 2Filippinene
-
University of California, DavisUnited States Agency for International Development (USAID); Global Alliance... og andre samarbeidspartnereAvsluttetUnderernæring | Kronisk sykdom | Underernæring, barn | Mangel på mikronæringsstofferHaiti
-
HIV Prevention Trials NetworkLondon School of Hygiene and Tropical Medicine; National Institute on Drug... og andre samarbeidspartnereFullførtHIVZambia, Sør-Afrika
-
University College, LondonLondon School of Hygiene and Tropical Medicine; Radboud University Medical... og andre samarbeidspartnereRekrutteringLungetuberkuloseSør-Afrika